IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13
A study presented at the Infectious Diseases Society of America’s IDWeek meeting found that starting HPV vaccination at ages 9–10, rather than 11–12, improves initiation and completion rates by age 13. The findings support earlier vaccination to increase coverage among adolescents.
HPV vaccine vaccination adolescents vaccine completion IDWeek
Linked Entities
Contributing Articles
Reversing radiation-activated immune suppression in cancer
Medical Xpress —
Acumen Pharmaceuticals: Altitude-AD Failure Destroys The Investment Thesis (Rating Downgrade)
Seeking Alpha —
Aura Biosciences: A Pivotal Trial Engineered With Room To Spare
Seeking Alpha —
The FDA wants to pull its approval of a drug. It’s not so easy.
Ars Technica —
An AI Agent Injected Drugs Into a Live Mouse’s Brain
Wired —
Viking Therapeutics: A Strong Injection, A Scaled-Back Pill
Seeking Alpha —
PepGen: Maintaining 'Hold,' PGN-EDODM1 Data Is A Major Inflection Point
Seeking Alpha —
Inovio Pharmaceuticals gets FDA approval for first product
Investing.com —
Popular hair products recalled over ‘serious injury’ and ‘poisoning’ risks: Return ASAP
Harrisburg Patriot-News —
Popular space heaters sold nationwide by major retailers recalled after suddenly catching fire
Harrisburg Patriot-News —